Monday, 13 October 2014

C-peptide concentration, mortality and vascular complications in people with Type 2 diabetes. The Skaraborg Diabetes Register

Measurement of C-peptide concentration at diagnosis could help identify patients who are at high risk and who presumably would benefit from more intensive treatment (Diabetic Medicine)


Predictive models for all-cause and cardiovascular mortality in type 2 diabetic inpatients. A cohort study

This study provides tools to predict premature mortality in type 2 diabetic inpatients (International Journal of Clinical Practice)


Plasma triglycerides predict ten-years all-cause mortality in outpatients with type 2 diabetes mellitus: a longitudinal observational study

This finding suggests that more attention should be given to the management of cardiovascular risk in type 2 diabetic patients with high triglycerides levels (Cardiovascular Diabetology)

No comments:

Post a Comment